Strategic opportunities in the thin film drug manufacturing market will grow to USD 16.5 billion by 2034 and drive industry growth

The production of pharmaceuticals using thin-film technology is revolutionizing drug delivery and enabling rapid and convenient absorption.

Wilmington, Delaware, United States, Transparency Market Research, Inc., August 21, 2024 (GLOBE NEWSWIRE) — According to the Transparency Market Researchthe global Thin film drug manufacturing market (박막 의약품 제조 Tienda) was worth it in US dollars 6.4 billion in 2023 and is expected 16.5 billion US dollars by 2034 at a CAGR from 9.0% between 2024 and 2034.

Thin film drug manufacturing involves creating thin layers of medication that can be administered in a variety of ways, such as orally, sublingually (under the tongue), or transdermally (through the skin). These thin films are designed to dissolve quickly and release the drug directly into the bloodstream, offering several advantages over traditional dosage forms such as tablets or capsules.

Thin film medications are used in a variety of medications, including pain relief, nausea treatment, and chronic disease management. In addition, there are several types of thin film medications. For example, oral thin film medications dissolve in the mouth without water, making them convenient for patients who have difficulty swallowing. In addition, transdermal patches are applied to the skin and release the medication over a longer period of time, and buccal and sublingual thin film medications are placed in the cheek or under the tongue for rapid absorption.

Request a PDF sample of this report now!

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11525

Thin Film Drug Manufacturing Market – The Sliced ​​Version

The thin film drug manufacturing market is experiencing strong growth due to several key factors. One of the main drivers is the increasing demand for innovative drug delivery systems that increase patient compliance and improve treatment outcomes.

Drug delivery via thin films offers advantages such as ease of administration, rapid onset of action and improved bioavailability, making it particularly attractive for children and the elderly. As a result, the rising prevalence of chronic diseases and the growing need for targeted drug delivery systems are expected to fuel the growth of the thin film drug delivery market.

Furthermore, technological advancements such as the development of novel polymers and nanotechnology-based thin films are further improving the efficacy and versatility of these drug delivery systems. AI-driven analytics are being used to optimize formulation parameters and predict patient responses, resulting in more effective and tailored therapies. Therefore, the impact of these advances is expected to be irreversible as they not only improve patient outcomes but also reduce healthcare costs by minimizing side effects and improving drug efficacy.

The story continues

Such advances indicate an increasing focus on personalized medicine and the integration of artificial intelligence (AI) into drug formulation and manufacturing processes.

The future prospects for the thin film drug manufacturing market are promising. Continuous innovation and increasing use of these technologies are expected to ensure sustainable growth. The market is expected to continue to grow as pharmaceutical companies invest in research to explore new applications and improve existing formulations.

Unlock growth potential in your industry! Download PDF brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11525

What about regional insights into the thin film pharmaceutical manufacturing market?

Factors driving the market share of thin film drug manufacturing include a growing preference for novel drug delivery systems that improve patient compliance and convenience, an increasing number of chronic diseases such as cardiovascular disease, diabetes and neurological disorders, technological advances in drug formulation and manufacturing such as improvements in bioavailability and controlled release mechanisms, and a growing trend toward non-invasive treatment options.

According to PhRMA OrgMore than 5500 companies were involved in advanced research on drug delivery technologies in 2022. It goes on to say that the major players have more than 101.0 billion US dollars in the innovation of film-coated drug production.

Key players in the thin film drug manufacturing industry

Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, AbbVie, Sumitomo Pharma Co., Ltd, IntelGenx Corp., NAL Pharma, ZIM Laboratories Limited, Indivior PLC and MonoSol are some of the leading players in the global industry, working to develop next-generation therapies to address unmet medical needs and improve patients' lives.

Current key developments

In July 2023, Redwood Scientific Technologies Inc., a leading pharmaceutical company based in New York, USA, announced the filing of a new patent for an advanced Oral Thin Film (OTF) manufacturing system. The innovation underscores Redwood's commitment to developing revolutionary drug delivery systems.

Market segmentation for the production of thin film medicines

product

• Oral thin film

• Sublingual film

• Fully dissolving dental/buccal film

• Transdermal thin film

• Others (Ocular Thin Film etc.)

Disease indication

schizophrenia

• migraine

• Opioid addiction

• Nausea and vomiting

• Miscellaneous

Sales channel

• Hospital pharmacies

• Drugstores

• Retail pharmacies

• Ecommerce

Buy this premium research report: https://www.transparencymarketresearch.com/checkout.php?rep_id=11525